Vahlteich Medicinal Chemistry Core Provides Support in Finding "Off" Switch for Scleroderma

U-M researchers are in the news for their role in identifying a signaling pathway that switches on scleroderma, a rare and sometimes fatal disease that causes skin and other tissue to thicken and has no cure. Medicinal chemistry support for the project is being provided by the Valhteich Medicinal Chemistry Core, directed by Scott Larsen, Ph.D., Research Professor of Medicinal Chemistry in the College of Pharmacy.

Read the full article.